{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:50:30Z","timestamp":1769849430460,"version":"3.49.0"},"reference-count":24,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1111\/dth.13221","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T05:04:34Z","timestamp":1578719074000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pyoderma gangrenosum adverse event with Rituximab use: A postmarketing pharmacovigilance analysis"],"prefix":"10.1155","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5271-8127","authenticated-orcid":false,"given":"Pushkar","family":"Aggarwal","sequence":"first","affiliation":[{"name":"University of Cincinnati College of Medicine  Cincinnati Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-016-0067-4"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2019.1619693"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2018.1438269"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050466"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.04.019"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000043"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12274"},{"key":"e_1_2_8_9_1","unstructured":"Drugs@FDAn.d. FDA approved drug products. Retrieved fromhttps:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.677"},{"key":"e_1_2_8_11_1","unstructured":"FDA.2019. Research C for DE and. FDA Adverse Event Reporting System (FAERS): Latest Quarterly Data Files. Retrieved fromhttp:\/\/www.fda.gov\/drugs\/questions\u2010and\u2010answers\u2010fdas\u2010adverse\u2010event\u2010reporting\u2010system\u2010faers\/fda\u2010adverse\u2010event\u2010reporting\u2010system\u2010faers\u2010latest\u2010quarterly\u2010data\u2010files"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.09.003"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389201003379059"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1159\/000091255"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.09.001"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000447"},{"key":"e_1_2_8_17_1","unstructured":"SchadtC CallenJ OforiA.Pyoderma gangrenosum: Pathogenesis clinical features and diagnosis.2019."},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-015-0478-5"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.4397"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2001.01501.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630410031909"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2016.1241298"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0b013e3181eb30ff"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01980"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-19"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.13221","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.13221","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dth.13221","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dth.13221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:55:08Z","timestamp":1671818108000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.13221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1111\/dth.13221"],"URL":"https:\/\/doi.org\/10.1111\/dth.13221","archive":["Portico"],"relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,17]]},"assertion":[{"value":"2019-12-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}